These results suggest that adenocarcinoma may include more EDIL3-positive cells and respond more robustly to EDIL3 than squamous cell carcinoma, resulting in tumor angiogenesis, presence of a mesenchymal phenotype, and poor clinical outcome. Here, EDIL3 is linked to neoplasm.